Tags

Type your tag names separated by a space and hit enter

Early tocilizumab treatment could improve survival among COVID-19 patients.
Clin Exp Rheumatol. 2020 May-Jun; 38(3):578.CE

Authors+Show Affiliations

Campins L
Department of Pharmacy, Hospital de Mataró, CSdM, Mataró, Barcelona, Spain. lcampins@csdm.cat.
Boixeda R
Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona; Grup d'Estudi al Maresme de la Pneumònia Adquirida en la Comunitat i la MPOC (GEMP@C), Mataró, Barcelona; and Universidad de Barcelona, CIBERES Barcelona, Spain.
Perez-Cordon L
Department of Pharmacy, Hospital de Mataró, CSdM, Mataró, Barcelona, Spain.
Aranega R
Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona, Spain.
Lopera C
Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona, Spain.
Force L
Department of Internal Medicine, Hospital de Mataró, CSDM, Mataró, Barcelona, and ESCS-TCMM, Pompeu Fabra University, Mataró, Barcelona, Spain.

MeSH

Adrenal Cortex HormonesAntibodies, Monoclonal, HumanizedBetacoronavirusBiomarkersCOVID-19Coronavirus InfectionsFemaleHumansMaleMiddle AgedPandemicsPneumonia, ViralSARS-CoV-2

Pub Type(s)

Letter

Language

eng

PubMed ID

32456769

Citation

Campins, Lluis, et al. "Early Tocilizumab Treatment Could Improve Survival Among COVID-19 Patients." Clinical and Experimental Rheumatology, vol. 38, no. 3, 2020, p. 578.
Campins L, Boixeda R, Perez-Cordon L, et al. Early tocilizumab treatment could improve survival among COVID-19 patients. Clin Exp Rheumatol. 2020;38(3):578.
Campins, L., Boixeda, R., Perez-Cordon, L., Aranega, R., Lopera, C., & Force, L. (2020). Early tocilizumab treatment could improve survival among COVID-19 patients. Clinical and Experimental Rheumatology, 38(3), 578.
Campins L, et al. Early Tocilizumab Treatment Could Improve Survival Among COVID-19 Patients. Clin Exp Rheumatol. 2020 May-Jun;38(3):578. PubMed PMID: 32456769.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Early tocilizumab treatment could improve survival among COVID-19 patients. AU - Campins,Lluis, AU - Boixeda,Ramon, AU - Perez-Cordon,Laia, AU - Aranega,Raquel, AU - Lopera,Carlos, AU - Force,Lluis, Y1 - 2020/05/27/ PY - 2020/05/17/received PY - 2020/05/20/accepted PY - 2020/5/28/entrez PY - 2020/5/28/pubmed PY - 2020/6/5/medline SP - 578 EP - 578 JF - Clinical and experimental rheumatology JO - Clin Exp Rheumatol VL - 38 IS - 3 SN - 0392-856X UR - https://www.unboundmedicine.com/medline/citation/32456769/Early_tocilizumab_treatment_could_improve_survival_among_COVID_19_patients_ DB - PRIME DP - Unbound Medicine ER -